These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8066157)

  • 1. Imipramine in alopecia areata. A double-blind, placebo-controlled study.
    Perini G; Zara M; Cipriani R; Carraro C; Preti A; Gava F; Coghi P; Peserico A
    Psychother Psychosom; 1994; 61(3-4):195-8. PubMed ID: 8066157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study comparing paroxetine placebo and imipramine in depressed patients.
    Feighner JP; Cohn JB; Fabre LF; Fieve RR; Mendels J; Shrivastava RK; Dunbar GC
    J Affect Disord; 1993 Jun; 28(2):71-9. PubMed ID: 8354771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM; Prusoff B; Sholomskas AJ; Greenwald S
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety.
    Lai VWY; Chen G; Gin D; Sinclair R
    J Am Acad Dermatol; 2019 Sep; 81(3):694-701. PubMed ID: 31048013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
    Salzmann E; Robin JL
    Neuropsychobiology; 1995; 31(2):68-75. PubMed ID: 7760988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
    Baldwin DS; Green M; Montgomery SA
    Int Clin Psychopharmacol; 2014 Nov; 29(6):339-43. PubMed ID: 24859491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata.
    Mikhaylov D; Pavel A; Yao C; Kimmel G; Nia J; Hashim P; Vekaria AS; Taliercio M; Singer G; Karalekas R; Baum D; Mansouri Y; Lebwohl MG; Guttman-Yassky E
    Arch Dermatol Res; 2019 Jan; 311(1):29-36. PubMed ID: 30417279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ritanserin, imipramine, and placebo in the treatment of dysthymic disorder.
    Bakish D; Lapierre YD; Weinstein R; Klein J; Wiens A; Jones B; Horn E; Browne M; Bourget D; Blanchard A
    J Clin Psychopharmacol; 1993 Dec; 13(6):409-14. PubMed ID: 8120154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA; Argyle N; Klerman GL
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amoxapine and imipramine in the treatment of depressed outpatients: a controlled study.
    Rickels K; Case WG; Werblowsky J; Csanalosi I; Schless A; Weise CC
    Am J Psychiatry; 1981 Jan; 138(1):20-4. PubMed ID: 7446776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.
    Kahn RJ; McNair DM; Lipman RS; Covi L; Rickels K; Downing R; Fisher S; Frankenthaler LM
    Arch Gen Psychiatry; 1986 Jan; 43(1):79-85. PubMed ID: 3510602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.